FDA greenlights Pfizer’s ABRYSVO vaccine for shielding infants from RSV

Pallavi Madhiraju- August 23, 2023 0

The US Food and Drug Administration (FDA) has granted approval to Pfizer Inc.'s ABRYSVO, a bivalent Respiratory Syncytial Virus prefusion F (RSVpreF) vaccine. This cutting-edge ... Read More

Getting Involved in Preventing Pediatric Medication Errors

pharmanewsdaily- February 17, 2017 0

Visiting the doctor is not often an enjoyable experience, as it is typically prompted by a health concern or ongoing medical issue which needs addressing. ... Read More